Agilent Technologies is attending the NICo conference on Core Facilities in Chieti on September 3 and 4, 2026.
Public source
Publisher name
Public post
🔬 Agilent è presente al Congresso NICo sulle Core Facilities, il 3 e 4 settembre a Chieti, con l’intero portafoglio di soluzioni a supporto dell’analitica avanzata. 🧬…
Company
Agilent Technologies
Let’s Bring Great Science to Life.
- Industry
- Biotechnology Research
- Location
- Santa Clara, US
- Company size
- 10,001+ employees
About Agilent Technologies
Agilent customers are finding new ways to treat cancer, ensure food, water, air, and medicine quality and safety, discover new drug treatments, research infectious diseases, and create alternative energy solutions for a greener planet. From start to finish, we have them covered with our vast product solutions and services portfolio. Around the world, Agilent’s people bring innovations, technologies, and services to the forefront of science. Our teams design and manufacture a wide array of advanced analytical, research, and diagnostic solutions and tools for use inside and outside laboratories. Additionally, the unique expertise of Agilent’s CrossLab and technical teams provides valuable insight and support to our customers, helping them fully optimize their laboratories and resources to better focus on what's important: bringing great science to life. In fiscal 2022, Agilent Technologies generated revenue of (US) $6.85 billion.
See moreLatest activity
Latest activity from Agilent Technologies
41 signals
Products & Services
Agilent Technologies introduced the new Agilent Plasmid Topology kit for the 5200 and 5300 Fragment Analyzer systems.
Products & Services
Agilent Technologies launched the new UltiMetal Thermal Desorption Tube portfolio designed to minimize adsorption at active metal sites to support more consistent recovery and reproducibility for trace-level compounds.
Customers & Market
Agilent Technologies received an update from ProMab Biotechnologies, Inc. highlighting their CAR-T development capabilities, including the use of NovoCyte flow cytometry and xCELLigence real-time cell analysis plots.
Discover more
Similar signals
Similar public activity from other companies.
Presence & Recognition
Euroclone SpA
Euroclone SpA is attending the third Congress of the Italian Core Facilities Network, NICo, at the University of G. d’Annunzio in Chieti-Pescara.
Presence & Recognition
Aurogene Srl
Aurogene Srl participated in the 3rd National Conference of the Italian Core Facilities Network at Università degli Studi G.d’Annunzio Chieti-Pescara alongside partners Cytek Biosciences and iotaSciences.
Presence & Recognition
Waters Corporation
Waters Corporation participated in the NICO conference in Chieti.
Presence & Recognition
Vetagro
Vetagro is presenting at the 11th Scientific Symposium on In Vitro Platforms for Screening Natural Anticoccidians at the SIPA event on 11 September 2026 at the Alma Mater Studiorum University of Bologna in Ozzano dell’Emilia.
Presence & Recognition
AHSI S.p.A. Soluzioni multidisciplinari per il laboratorio